Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has received authorization from the U.S.…
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized…
InMed Pharmaceuticals (NASDAQ: INM) recently filed a Patent Cooperation Treaty (“PCT”) application, which specifies a rare cannabinoid (new to InMed’s…
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, owns and partners with multiple synergistic businesses working to create…
Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, today announced…
PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is reporting its interim unaudited consolidated financial results for the three and six months…
The global COVID pandemic has had a significant impact on the world’s markets, but a basic optimism has generally persisted…
MINDCURE plans to schedule a pre-IND meeting with the FDA for its Desire Project during Q1 2022 with a subsequent…
MCOA’s Q3 2021 revenue increased 731% year on year from $53,195 in Q3 2020 to $442,178 in Q3 2021 The…
The pharmacy practice is undergoing an evolution that will see pharmacies play a more significant role in patient care Expanded…